TEMPUS AI
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying TEMPUS AI's stock with a target price of $97, indicating strong growth potential.
Financial Health
TEMPUS AI is earning strong revenue and cash flow, indicating good financial stability and growth potential.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring TEM
Nvidia Intel Partnership: Beyond the $5B Deal
Nvidia announced a $5 billion investment in Intel, marking a significant partnership between the two semiconductor rivals to jointly develop AI-focused chips. This collaboration could create opportunities for other companies in the semiconductor supply chain and AI software development.
Published: September 19, 2025
Explore BasketUS-UK Tech Alliance | Nvidia CEO Joins Diplomatic Trip
Nvidia's CEO is joining a diplomatic trip to the UK, signaling a new era of corporate-led efforts to boost transatlantic technology partnerships. This initiative is expected to drive investment into AI, semiconductor, and energy companies in both the US and the UK.
Published: September 9, 2025
Explore BasketPerformance-Linked AI Leadership Explained
Tesla's proposal of a massive, performance-linked pay package for Elon Musk highlights its aggressive growth strategy. This move, which also involves investment in Musk's xAI, creates an investment theme centered on companies that tie executive incentives to ambitious innovation and AI expansion.
Published: September 8, 2025
Explore BasketMobile AI's Antitrust Challenge
Elon Musk's companies are suing Apple and OpenAI, alleging their partnership creates an anti-competitive monopoly in the AI space. This legal battle could unlock the mobile AI market for competitors, creating a significant growth opportunity for other AI technology firms.
Published: August 27, 2025
Explore BasketAI Talent Market Shifts: Tech Stocks to Watch 2025
Meta has frozen hiring in its AI division, creating a potential shift in the highly competitive talent market. This presents an opportunity for other major tech firms to attract top researchers and engineers who are now available.
Published: August 22, 2025
Explore BasketPowering the AI Revolution: OpenAI's Valuation Catalyst
OpenAI's recent employee stock sale has launched its valuation to an estimated $500 billion, backed by major investors like SoftBank. This event signals a massive acceleration in AI development, creating potential opportunities for companies that provide the critical infrastructure and technology powering this growth.
Published: August 18, 2025
Explore BasketHealthcare's Compliance Catalyst
The Department of Justice's investigation into UnitedHealth's billing practices is increasing pressure on the entire healthcare industry to ensure compliance. This regulatory focus creates an investment opportunity in companies that provide specialized technology for transparent and accurate medical billing.
Published: July 26, 2025
Explore BasketAI Governance And Compliance Technology
This carefully selected group of stocks focuses on companies helping businesses navigate the complex world of AI regulations. As tensions rise between tech giants and regulators, these companies provide the essential tools and services organizations need to stay compliant and avoid costly penalties.
Published: July 21, 2025
Explore BasketAI Compliance Divergence: RegTech Solutions for EU Standards
This carefully selected group of stocks represents companies at the forefront of AI governance and compliance solutions. Our professional analysts have identified these opportunities emerging from the regulatory divide between tech giants like Microsoft and Meta, as businesses increasingly need specialized help to navigate complex AI rules.
Published: July 20, 2025
Explore BasketRegTech Automation Vendors
Get exposure to innovative companies using AI to tackle complex financial regulations. These carefully selected stocks represent leaders in automated compliance solutions - a growing necessity in today's highly regulated financial world.
Published: June 17, 2025
Explore BasketAI-Driven Drug Discovery
These groundbreaking companies are redefining pharmaceutical research with artificial intelligence. Each has been carefully selected by our analysts for their potential to develop life-saving drugs faster and more efficiently than traditional methods allow.
Published: June 17, 2025
Explore BasketPersonalized Medicine Portfolio
This collection features innovative companies revolutionizing healthcare by developing treatments tailored to individual genetic profiles. Carefully selected by our analysts, these stocks represent the cutting edge of precision medicine, where customized therapies aim to deliver more effective patient outcomes.
Published: June 17, 2025
Explore BasketNew Moon Portfolio
This collection represents the very beginning of the next technological cycle. These carefully selected companies are sowing the seeds of future industries, giving you early exposure to disruptive innovators poised for exponential growth as their technologies reshape our world.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Growth from AI adoption
Investors may watch enterprise uptake and recurring revenue as signs of sustainable expansion, though growth can be uneven and valuation‑sensitive.
R&D and cash flow
Heavy spending on models and infrastructure can spur innovation but pressure margins and cash flow; monitor profitability trends closely.
Regulation and competition
Data rules and large competitor strategies shape the opportunity; regulatory changes or aggressive moves by incumbents can alter the outlook quickly.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
